irsogladine has been researched along with Cancer of Pancreas in 1 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, Y | 1 |
| Tsuchida, A | 1 |
| Sasaki, T | 1 |
| Yamasaki, S | 1 |
| Kuwada, Y | 1 |
| Murakami, M | 1 |
| Chayama, K | 1 |
1 other study available for irsogladine and Cancer of Pancreas
| Article | Year |
|---|---|
Irsogladine malate up-regulates gap junctional intercellular communication between pancreatic cancer cells via PKA pathway.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Communication; Cell Line; Connexin 43; Cy | 2002 |